ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Ultra納斯達克生物科
109.77
+1.34
1.23%
成交量：
1,798
成交額：
19.71萬
市值：
9,220.50萬
市盈率：
- -
高：
109.77
開：
109.74
低：
108.70
收：
108.43
52周最高：
126.40
52周最低：
55.34
股本：
84.00萬
流通股本：
84.00萬
量比：
0.42
換手率：
0.21%
股息：
0.33
股息率：
0.30%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
安進提交新數據，對美國食品藥品監督管理局（FDA）關於撤回Tavneos的提議提出異議
路透中文
·
07/24
吉利德科學(GILD)腫瘤組合療法獲歐洲藥品管理局旗下CHMP推薦
金吾财讯
·
07/24
CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌
美股速递
·
07/24
百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期
新浪医药
·
07/23
數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法
路透中文
·
07/22
吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒
路透中文
·
07/22
安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解
路透中文
·
07/21
Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元
美股速递
·
07/21
Leerink下調吉利德科學目標價至127美元
格隆汇
·
07/21
Kalshi將允許對臨床試驗和FDA決定進行投注
路透中文
·
07/16
剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗
路透中文
·
07/14
Vertex(VRTX)百億美元收購罕見病藥企 拓寬內分泌管線佈局
金吾财讯
·
07/13
福泰製藥百億美元併購透露了什麼訊號？
蓝鲸财经
·
07/11
吉利德科學(GILD)股票7月10日盤中下跌3.26%：關鍵驅動因素揭曉
TradingKey中文
·
07/11
BUZZ——美國股市動態-SK海力士、達美航空、Circle Internet
路透中文
·
07/10
滙豐表示，生物製藥領域的併購交易有望創下年度新高
路透中文
·
07/10
福泰製藥(VRTX)股票7月8日盤中下跌3.09%：投資者必看的核心信息
TradingKey中文
·
07/09
大摩解讀福泰製藥百億收購Crinetics：補齊內分泌管線佈局 兩大核心藥物打開增長空間
智通财经
·
07/08
RBC Capital上調福泰製藥目標價至570美元
格隆汇
·
07/08
吉利德科學(GILD)股票7月7日收盤上漲5.35%：原因全解讀
TradingKey中文
·
07/08
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/BIB/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"Ultra納斯達克生物科","latestPrice":109.7679,"timestamp":1789572123212,"preClose":108.43,"halted":0,"volume":1798,"delay":0,"changeRate":0.012338836115466111,"floatShares":840000,"shares":840000,"eps":0,"marketStatus":"交易中","change":1.3379,"latestTime":"09-16 11:28:36 EDT","open":109.735,"high":109.7679,"low":108.6985,"amount":197087.28454,"amplitude":0.009863,"askPrice":109.79,"askSize":100,"bidPrice":109.51,"bidSize":20,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":108.43,"sharesOutstanding":1040000,"nav":111.7314,"aum":93854376,"dividendRate":0.002964,"bidAskSpread":0.002339,"postHourTrading":{"tag":"盘后","latestPrice":108.43,"preClose":108.43,"latestTime":"19:30 EDT","volume":12,"amount":1301.16,"timestamp":1789515007137,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.416627,"impliedVol":0.3949,"impliedVolPercentile":0.0916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.416627,"shares":840000,"dividePrice":0.3253,"high":109.7679,"amplitude":0.009863,"preClose":108.43,"low":108.6985,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":109.7679,"committee":-0.666667,"eps":0,"divideRate":0.002964,"volume":1798,"delay":0,"ttmEps":0,"open":109.735,"prevYearClose":79.7794,"prevWeekClose":109.7741,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":112.8071,"twentyDayClose":111.9849,"sixtyDayClose":88.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653080634","title":"安進提交新數據，對美國食品藥品監督管理局（FDA）關於撤回Tavneos的提議提出異議","url":"https://stock-news.laohu8.com/highlight/detail?id=2653080634","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653080634?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 21:44","pubTimestamp":1784900670,"startTime":"0","endTime":"0","summary":"安进提交新数据，对美国食品药品监督管理局关于撤回Tavneos的提议提出异议路透7月24日-安进公司周五表示，该公司已于7月23日向美国食品药品监督管理局提交了新证据，以寻求举行听证会，对该公司的罕见病药物Tavneos拟从美国市场撤回的决定提出异议。美国食品药品监督管理局未立即回应路透的置评请求。美国食品药品监督管理局今年4月表示，除非安进公司主动撤回该药，或FDA局长下令撤回，否则Tavneos将继续在美国市场销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL4T43Q16X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU2112291526.USD","LU1057294990.SGD","PJP","BK4588","SG9999001440.SGD","IBB","BK4533","LU0320765992.SGD","BBH","BK4534","LU1571399168.USD","LU1061106388.HKD","BK4566","LU0868494617.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0289739699.SGD","BK4139","LU1983299246.USD","IE0002141913.USD","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","TBXU","AMGN","BK4585","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","PBE","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4599","IBBQ","LU2242646821.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653895100","title":"吉利德科學(GILD)腫瘤組合療法獲歐洲藥品管理局旗下CHMP推薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2653895100","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653895100?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 18:45","pubTimestamp":1784889935,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学 宣布，欧洲药品管理局旗下人用药品委员会已发布积极意见，建议批准其Trop-2靶向ADC药物Trodelvy联合帕博利珠单抗，用于既往未接受过全身治疗、且肿瘤PD-L1表达阳性的不可切除局部晚期或转移性三阴性乳腺癌成人患者。若欧盟委员会于2026年晚些时候正式批准该联合疗法，Trodelvy将实现从单药到联合疗法、全面覆盖不同PD-L1表达状态的mTNBC一线治疗布局。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302998","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","IBB","BK4139","LU2468319806.SGD","TBXU","LU0320765992.SGD","MEDI","IE0002270589.USD","LU2089984988.USD","IE00BSNM7G36.USD","LU0823416689.USD","LU1934455194.USD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1037948541.HKD","LU1585245621.USD","SG9999015945.SGD","LU0122379950.USD","GILD","BIB","SG9999015978.USD","LU0965509101.SGD","LU0965508806.USD","LU2324357040.USD","CHMP","LU1571399168.USD","BK4588","SG9999015952.SGD","LU1061106388.HKD","LU1934455863.HKD","BK4583","LU2087621335.USD","BMED","BK4550","IBBQ","LU0058720904.USD","LU0234570918.USD","TMED","BK4585","LU0889565916.HKD","LU1023059063.AUD","IE00B19Z3581.USD","IE00B3T34201.USD","LU1066051498.USD","BK4568","SG9999015986.USD","BBH","LU1057294990.SGD","LU0289739699.SGD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185859812","title":"CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1185859812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185859812?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 18:29","pubTimestamp":1784888958,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用药品委员会（CHMP）近日给出推荐意见，支持吉利德科学的Trodelvy®与Keytruda®联合使用，用于治疗PD-(L)1阳性的一线转移性三阴性乳腺癌患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","IE00B7SZLL34.SGD","TMED","LU2112291526.USD","LU1430594728.SGD","BK4568","BK4139","LU1571399168.USD","IE0002270589.USD","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU1778281490.HKD","LU1934455863.HKD","LU0234570918.USD","LU0861579265.USD","SG9999015978.USD","LU1037948541.HKD","LU2089984988.USD","LU1934455194.USD","IE00B19Z3B42.SGD","GILD","BMED","IE00BZ1G4Q59.USD","BK4585","LU0289739699.SGD","TBXU","BK4578","LU0122379950.USD","BK4588","IBB","SG9999015945.SGD","LU2468319806.SGD","LU1057294990.SGD","LU1839511570.USD","LU1061106388.HKD","LU1023059063.AUD","IE00BSNM7G36.USD","LU1585245621.USD","LU0058720904.USD","IE00B3T34201.USD","IBBQ","LU0965509101.SGD","BIB","LU1674673691.USD","BK4532","SG9999015986.USD","LU0320765992.SGD","BBH","LU0965509283.SGD","LU0109394709.USD","LU0965509010.AUD","LU1066051498.USD","MEDI","LU2324357040.USD","BK4583","LU1066053197.SGD","LU1674673428.USD","LU0889565916.HKD","SG9999015952.SGD","LU0965508806.USD","BK4550","LU0114720955.EUR","LU0882574055.USD","LU1934455277.USD","LU1037948897.HKD","LU0823416689.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653074709","title":"百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期","url":"https://stock-news.laohu8.com/highlight/detail?id=2653074709","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653074709?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 19:30","pubTimestamp":1784806200,"startTime":"0","endTime":"0","summary":"7 月 22 日，药物临床试验登记与信息公示平台显示，安进和百济神州共同登记了一项在接受含铂一线化疗后的复发性广泛期小细胞肺癌试验参与者中比较 Tarlatamab皮下给药与静脉给药的 III 期研究DeLLphi-315。在皮下剂型的开发方面，安进和百济神州于 2024 年 9 月启动了一项在广泛期小细胞肺癌受试者中评价 Tarlatamab 皮下给药的安全性、耐受性、药代动力学和初步抗肿瘤活性的 Ib 期研究 DeLLphi-308。而本次启动的DeLLphi-315 研究是塔拉妥单抗皮下给药方案启动的首个 III 期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-23/doc-iniivazc5268721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06160","LU0058720904.USD","LU2242646821.SGD","LU1251922891.USD","BK4588","LU0868494617.USD","IE00B4R5TH58.HKD","TBXU","BK4581","LU0122379950.USD","BK1588","IBB","IE0002141913.USD","IE0009355771.USD","PBE","BK1500","LU2242652126.USD","IE00BJT1NW94.SGD","LU2328871848.SGD","688235","III","LU0320765992.SGD","BK4599","LU1969619763.USD","LU0289739699.SGD","SG9999001440.SGD","LU2468319806.SGD","ONC","IE00BFTCPJ56.SGD","AMGN","LU0889565916.HKD","LU2112291526.USD","LU0588546209.SGD","BBH","BK4134","LU1983299246.USD","PJP","BK4534","IBBQ","BK4139","BIB","LU0307460666.USD","LU1061106388.HKD","KURE","LU1303224171.USD","LU1770034418.SGD","LU1719994722.HKD","BK4585","LU1571399168.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653618768","title":"數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2653618768","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653618768?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:52","pubTimestamp":1784724736,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法更新疫情数据，补充临床试验进展及诊断检测详情Mariam Sunny/Jennifer Rigby路透7月22日-全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部由邦迪布吉奥 埃博拉病毒株引发的疫情。与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。据该公司称，实验室研究表明该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1015430645.USD","LU1430594728.SGD","BK4568","REGN","LU3187612489.SGD","IE00BJJMRZ35.SGD","LU2361044865.SGD","LU0920840948.USD","LU0661504455.SGD","LU1355424745.HKD","LU0124676726.USD","LU0047473722.EUR","LU1196032939.SGD","IHE","SG9999015945.SGD","LU2362541513.USD","LU1019632923.USD","LU0648001328.SGD","BK0239","LU0969580561.USD","LU0972486137.USD","LU2125154935.USD","BK4583","LU1261432733.SGD","LU1119994496.HKD","LU0171293334.USD","LU0784384876.USD","IE0009355771.USD","LU0889566641.SGD","LU0792757196.USD","IE00BKVL7J92.USD","LU1003076772.USD","LU0211328371.USD","LU0070302665.USD","LU0857590862.USD","BK4578","LU0234572021.USD","LU0868494617.USD","LU0238689110.USD","LU0882574055.USD","LU0320765992.SGD","LU1481599808.USD","LU1153584641.USD","LU0640478417.SGD","LU0784385840.USD","LU2125909247.SGD","LU2114397693.USD","LU1989772840.SGD","LU1084165304.USD","LGHT","LU1571399168.USD","LU0310799852.SGD","BIB","SG9999014567.USD","BK4559","IE00BFTCPJ56.SGD","IE00B7SZLL34.SGD","LU1267930573.SGD","LU0114720955.EUR","LU1093756168.USD","LU1066051811.HKD","SG9999015986.USD","LU1037948541.HKD","GILD","SG9999014575.USD","LU0011850046.USD","IE00B4R5TH58.HKD","LU2237443978.SGD","LU1051770623.HKD","LU1699723380.USD","LU1923622614.USD","LU0942090050.USD","LU1839511570.USD","LU0889565080.SGD","LU2491050154.USD","LU0499090636.EUR","IE00BLSP4239.USD","LU0203347892.USD","BK4533","LU0738911758.USD","LU0868494708.USD","LU0997586515.USD","LU1323610961.USD","AZN.UK","LU2087621335.USD","LU2089283258.USD","LU1929549753.HKD","LU0266013472.USD","LU0965509010.AUD","LU1496350502.SGD","LU2361044949.HKD","LU0310800379.SGD","BK4550","LU2433249047.HKD","BMED","LU0784383803.USD","TRUH","LU0098860793.USD","LU2089284900.SGD","LU1863844665.USD","LU2089984988.USD","LU0997586432.USD","LU1941712348.USD","LU0047473722.SGD","LU2360032135.SGD","LU0496365809.HKD","BK4588","LU0823416689.USD","GDOC","BK4534","LU0029864427.USD","LU2133065610.SGD","LU0965508806.USD","LU0823399737.USD","BK4532","LU0077335932.USD","LU0960981461.USD","LU0980610538.SGD","MRK","LU2362541273.HKD","LU0887340254.USD","IE0002270589.USD","LU0949170772.SGD","IE00BKPKM643.USD","LU1291159041.SGD","LU1941712264.USD","LU2237438978.USD","SG9999015952.SGD","LU0130517989.USD","LU0963555726.SGD","LU1487256676.USD","LU2237443549.SGD","IE00BN8TJ469.HKD","LU2125909593.SGD","LU1019634622.SGD","LU0234570918.USD","LU1496350171.SGD","TMED","LU0823434740.USD","LU0557290698.USD","JDOC","LU0128525929.USD","XLV","LU2023250504.SGD","LU2106854487.HKD","LU0861579265.USD","LU0964806797.USD","LU1066051225.USD","LU0109394709.USD","LU2357627491.SGD","BBH","SG9999001176.USD","IE00B19Z3581.USD","LU0545039389.USD","LU2279689827.SGD","BK4007","LU0208291251.USD","LU2023250843.SGD","LU0265550946.USD","LU0211331839.USD","MRNY","LU1974910355.USD","SG9999002224.SGD","OSUR","PAWZ","LU1046234339.USD","LU1170363599.USD","SG9999015341.SGD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU0823434583.USD","LU0203345920.USD","WDNA","LU0920783379.SGD","LU2023251221.USD","IE0034235188.USD","LU2237443895.HKD","LU1061106388.HKD","LU0289739699.SGD","FHLC","LU1989771016.USD","SG9999015978.USD","LU0345777147.USD","LU1301847155.USD","IE00B19Z3B42.SGD","LU0052756011.USD","LU0211327993.USD","LU0827474353.SGD","LU0171276677.USD","LU0957799991.USD","LU1057294990.SGD","LU2491050071.SGD","BK4566","BK4585","LU0757432116.USD","IBBQ","IXJ","LU1983299246.USD","LU1201861249.SGD","LU0965509101.SGD","LU0949170426.SGD","LU0122379950.USD","LU0130102774.USD","LU1116320901.HKD","VHT","LU1069347547.HKD","IBB","LU2237443382.USD","SG9999013999.USD","LU2112291526.USD","LU0784385170.HKD","LU1273509221.SGD","HRTS","LU0211326839.USD","MRNX","LU2237443622.USD","LU1104425308.USD","MRNA","BK4139","LU0708994859.HKD","LU2293690249.USD","LU0965509283.SGD","IE00B3T34201.USD","LU0058720904.USD","LU0477156953.USD","BK5011","LU0211326755.USD","LU0526926950.USD","LU0128525689.USD","LU0553294199.USD","LU1481600234.SGD","LU1093756325.SGD","LU1814569148.SGD","BK4551","RXL","LU1863844749.USD","LU0320765646.SGD","SGXZ57979304.SGD","LU1023059063.AUD","GNOM","IE00B1BXHZ80.USD","LU0158827948.USD","LU0432979614.USD","IYH","LU1880407215.USD","LU1162221912.USD","IE00B2B36J28.USD","LU0689626769.HKD","LU0265550359.USD","LU0106261372.USD","SG9999002232.USD","LU0006306889.USD","LU1267930813.SGD","LU1066051498.USD","LU2461242641.AUD","LU2362540622.SGD","BK4501","LU1829250122.USD","PPH","SG9999014559.SGD","688317","IDNA","LU2539964713.USD","SG9999001176.SGD","LU0310800965.SGD","IE00BBT3K403.USD","LU1035773651.USD","LU2293690082.USD","LU1674673691.USD","LU1003077747.HKD","IE00BJT1NW94.SGD","LU0345777659.USD","LU1934455863.HKD","IE0002141913.USD","MEDI","IE00BZ1G4Q59.USD","LU2361045086.USD","LU1989772923.USD","SG9999015358.SGD","LU2237443465.HKD","LU1064927863.SGD","LU1153585028.USD","LU1934455277.USD","BK4516","BK4548","LU1934455194.USD","LU0889565916.HKD","LU1674673428.USD","LU1078025761.USD","LU1880407132.USD","LU0390134368.USD","LU1116320737.USD","LU2355687059.USD","LU2125154778.USD","SG9999001440.SGD","LU1267930490.SGD","LU1066053197.SGD","LU2491049909.HKD","LU1585245621.USD","LU1778281490.HKD","LU1917777945.USD","TBXU","LU0320765489.SGD","LU0859254822.USD","LU2324357040.USD","LU0053666078.USD","LU2091194634.USD","IE00BSNM7G36.USD","SG9999014542.SGD","BK4198","LU0985320562.USD","FTXH","LU1267930227.SGD","LU2468319806.SGD","LU0976567544.SGD","LU2108987350.USD","LU0575583348.USD","03165","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204798","title":"吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204798","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204798?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 01:23","pubTimestamp":1784654592,"startTime":"0","endTime":"0","summary":"吉利德与默克联合研发的每周服用一次的艾滋病口服药在晚期临床试验中成功抑制了病毒路透7月21日-吉利德科学公司和默克公司周二表示，其正在试验中的每周服用一次的艾滋病毒口服药在两项晚期临床试验中成功抑制了病毒，这为该药的监管申报提供了支持，该疗法有望成为此类疾病治疗中首个此类方案。默克公司的每日一次艾滋病口服复方制剂Idvynso已于4月获得美国食品药品监督管理局批准 ，为艾滋病患者提供了另一种治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014542.SGD","VHT","LU0266013472.USD","RXL","LU2023250843.SGD","LU0432979614.USD","TBXU","IE00B2B36J28.USD","LU1291159041.SGD","PPH","MRK","TMED","LU1778281490.HKD","LU1941712348.USD","LU2089984988.USD","LU0889565916.HKD","BMED","BIB","IE00BJJMRZ35.SGD","GILD","LU1066053197.SGD","LU1923622614.USD","LU1983299246.USD","BBH","HRTS","MEDI","JDOC","TRUH","GDOC","LU1699723380.USD","LU0861579265.USD","LU1929549753.HKD","SG9999001176.USD","LU1023059063.AUD","LU2087621335.USD","LU0058720904.USD","FHLC","LU1989771016.USD","IBBQ","LU2324357040.USD","XLV","IBB","LU0868494708.USD","IXJ","IYH","LU1093756168.USD","IHE","SG9999015952.SGD","FTXH","PAWZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653206285","title":"安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2653206285","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653206285?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 23:07","pubTimestamp":1784646437,"startTime":"0","endTime":"0","summary":"安进就股东提起的指控其隐瞒107亿美元税单的诉讼达成和解Jonathan Stempel路透纽约7月21日-安进公司就一起指控其延迟披露可能因六年税款申报不足而需向美国国税局补缴107亿美元的诉讼，达成了一项7400万美元的和解协议。安进否认有任何不当行为，并于周二表示仍认为这些指控毫无依据。美国国税局就安进公司所谓的“转让定价”做法，要求其补缴87亿美元税款及利息，并处以20亿美元罚款。安进公司表示，美国税务法院的裁决可能于今年作出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","BBH","BK4588","LU2112291526.USD","BK4533","BK4566","AMGN","BK4585","IBBQ","BIB","PBE","LU1571399168.USD","LU1983299246.USD","LU0289739699.SGD","BK4534","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","LU0058720904.USD","LU1057294990.SGD","LU0320765992.SGD","PJP","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","LU0889565916.HKD","IE0009355771.USD","BK4581","IE0002141913.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00B2B36J28.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","BK4599","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169878111","title":"Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169878111","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169878111?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 12:03","pubTimestamp":1784606620,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners调整了对生物技术公司吉利德科学的股票评级。该机构将其评级从原先的“跑赢大盘”下调至“与大盘持平”，反映出其对该公司近期前景更为审慎的看法。\n与此同时，Leerink Partners也显著下调了吉利德科学的目标股价，从每股146美元大幅削减至127美元。这一调整意味着该机构对该公司未来股价的预期有所降低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","BMED","LU0320765992.SGD","LU0889565916.HKD","LU1066051498.USD","LU1674673691.USD","MEDI","GILD","LU1057294990.SGD","LU1934455194.USD","LU1674673428.USD","LU1037948541.HKD","LU1839511570.USD","LU1037948897.HKD","SG9999015952.SGD","LU1778281490.HKD","IBBQ","LU1430594728.SGD","BK4578","LU2112291526.USD","TBXU","LU0965509101.SGD","BK4139","IBB","IE0002270589.USD","LU1934455863.HKD","LU2089984988.USD","LU0965508806.USD","BK4566","IE00BZ1G4Q59.USD","SG9999015945.SGD","BBH","LU1571399168.USD","IE00BKVL7J92.USD","LU0109394709.USD","LU0114720955.EUR","LU2468319806.SGD","TMED","BK4550","BK4568","BIB","LU0861579265.USD","SG9999015978.USD","LU0882574055.USD","LU0965509010.AUD","IE00BSNM7G36.USD","BK4583","IE00B7SZLL34.SGD","LU0122379950.USD","BK4532","LU0289739699.SGD","LU0058720904.USD","LU0965509283.SGD","LU1585245621.USD","LU1934455277.USD","LU1061106388.HKD","LU2087621335.USD","SG9999015986.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU1023059063.AUD","LU1066053197.SGD","BK4588","LU0823416689.USD","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653210240","title":"Leerink下調吉利德科學目標價至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653210240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653210240?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 10:35","pubTimestamp":1784601350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","LU0114720955.EUR","LU0058720904.USD","LU1778281490.HKD","LU1674673691.USD","LU1037948541.HKD","LU1023059063.AUD","IE00BZ1G4Q59.USD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1585245621.USD","BK4550","LU2468319806.SGD","SG9999015978.USD","BK4585","IE00B19Z3B42.SGD","LU0965509010.AUD","LU1066053197.SGD","BK4583","LU0109394709.USD","LU0965509101.SGD","LU0320765992.SGD","BMED","LU1674673428.USD","IE00BSNM7G36.USD","GILD","UUP","MEDI","BIB","UDN","LU0234570918.USD","IBBQ","LU2087621335.USD","BBH","LU0122379950.USD","LU0861579265.USD","LU1839511570.USD","LU1934455863.HKD","IE00B7SZLL34.SGD","LU0823416689.USD","LU2324357040.USD","BK4578","IBB","SG9999015986.USD","LU0965509283.SGD","LU2112291526.USD","LU0882574055.USD","LU2089984988.USD","SG9999015945.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652423028","title":"Kalshi將允許對臨床試驗和FDA決定進行投注","url":"https://stock-news.laohu8.com/highlight/detail?id=2652423028","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652423028?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 23:59","pubTimestamp":1784217550,"startTime":"0","endTime":"0","summary":"Kalshi将允许对临床试验和FDA决定进行投注路透7月16日-预测市场平台Kalshi周四表示，将开始接受针对临床试验结果和美国食品药品监督管理局监管审查结果的投注，这标志着药物研发的赔率首次向公众公开。Kalshi表示，这些市场允许投资者针对单一药物而非整个公司进行投注。Kalshi和AppliedXL将在试验完成受试者招募后才发布相关合约。Kalshi平台于2021年上线，允许用户对体育赛事、选举结果和天气等事件进行投注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nL4S43I1IP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","IE00B19Z3B42.SGD","LU1037948541.HKD","LU0823416689.USD","SG9999015978.USD","LU0889565916.HKD","BK4578","LU0965509283.SGD","SG9999015945.SGD","LU0122379950.USD","LU1585245621.USD","LU1839511570.USD","LU2112291526.USD","SMMT","LU0058720904.USD","BK4588","LU1066051498.USD","LU2089984988.USD","LU0965508806.USD","LU0109394709.USD","LU1934455277.USD","BIB","BK4585","LU1057294990.SGD","BMED","IE00BSNM7G36.USD","IE0002270589.USD","LU1674673428.USD","LU2324357040.USD","LU1934455863.HKD","IE00B7SZLL34.SGD","IBB","LU1571399168.USD","LU2087621335.USD","BK4532","IE00B19Z3581.USD","LU2468319806.SGD","LU0114720955.EUR","LU1037948897.HKD","LU1674673691.USD","SG9999015952.SGD","IBBQ","BBH","LU0861579265.USD","MEDI","BK4583","BK4566","GILD","LU0234570918.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105068","title":"剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105068","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105068?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 20:47","pubTimestamp":1784033246,"startTime":"0","endTime":"0","summary":"刚果启动吉利德实验性抗病毒药物邦迪布吉奥埃博拉病毒试验路透7月14日-刚果民主共和国的研究人员周二表示，他们已开始招募受试者，参与一项临床试验，测试吉利德科学公司GILD.O旗下实验性抗病毒药物奥贝德西韦作为刚果和乌干达当前邦迪布吉奥埃博拉疫情的暴露后治疗药物。在临床前研究中，奥贝德西韦已显示出对丝状病毒的活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nL4S43G1EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IBB","LU1778281490.HKD","LU2089984988.USD","LU1839511570.USD","LU1057294990.SGD","LU0965509010.AUD","LU1934455194.USD","MEDI","BK4550","LU0965508806.USD","BK4578","SG9999015986.USD","LU1585245621.USD","LU1430594728.SGD","LU0234570918.USD","LU1934455863.HKD","LU1571399168.USD","BK4583","BK4585","GILD","LU0965509283.SGD","BK4566","LU1934455277.USD","SG9999015978.USD","IE00BZ1G4Q59.USD","BMED","IE00BSNM7G36.USD","LU0861579265.USD","BK4588","LU1023059063.AUD","LU1674673691.USD","LU2324357040.USD","IE00BKVL7J92.USD","IBBQ","LU1061106388.HKD","IE0002270589.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0320765992.SGD","LU1066053197.SGD","BK4532","LU0823416689.USD","IE00B7SZLL34.SGD","LU1037948897.HKD","BIB","LU2468319806.SGD","IE00B19Z3B42.SGD","LU2087621335.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117599","title":"Vertex(VRTX)百億美元收購罕見病藥企 拓寬內分泌管線佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651117599?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals 与 Crinetics Pharmaceuticals 共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU2456880835.USD","SG9999001176.SGD","LU0566484027.USD","IE00B2B36J28.USD","LU0061475181.USD","LU1778281490.HKD","LU0889565916.HKD","VERX","IE00B19Z3581.USD","IBBQ","BIB","LU0234570918.USD","IBB","LU0757428866.USD","VRTX","LU1035775433.USD","BK4007","BK4585","LU2462157665.USD","IE0002270589.USD","IE0002141913.USD","LU1674673428.USD","BK4588","BK4532","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","LU0256863811.USD","LU1069344957.HKD","CRNX","LU2362541513.USD","SG9999001176.USD","SG9999013999.USD","LU1585245621.USD","PBE","LU0432979614.USD","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU0109394709.USD","LU1093756325.SGD","LU2362540622.SGD","LU2237438978.USD","LU2417539215.USD","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU1093756168.USD","IDNA","BBH","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650760159","title":"福泰製藥百億美元併購透露了什麼訊號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2650760159","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650760159?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 22:55","pubTimestamp":1783781749,"startTime":"0","endTime":"0","summary":"01百亿美元级现金并购的底气福泰制药2025年全年营收120.01亿美元，同比增长9%，非GAAP净利润47.5亿美元，毛利率维持85%以上高位，账面现金及有价证券超过123亿美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1783569458583958068","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0109394709.USD","LU0058720904.USD","LU2462157665.USD","SG9999001176.SGD","IBB","VRTX","LU2324357040.USD","KCE","BK4567","LU0061475181.USD","SG9999001176.USD","XMMO","BK4139","IE00B19Z3581.USD","BK4532","LU0320765992.SGD","LU1035775433.USD","LU1093756325.SGD","PBE","BIB","LU2236285917.USD","MYLD","IE00BZ9MQY76.HKD","LU2362540622.SGD","LU0823416689.USD","IE0002270589.USD","LU0289739699.SGD","LU1069344957.HKD","LU1093756168.USD","LU1778281490.HKD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","LU0079474960.USD","IBBQ","BBH","BK4588","LU1585245621.USD","IE0009355771.USD","CALF","LU2417539215.USD","IE00BJT1NW94.SGD","LU0234570918.USD","IE00B19Z9P08.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","SGXZ57979304.SGD","IDNA","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650131357","title":"吉利德科學(GILD)股票7月10日盤中下跌3.26%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2650131357","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650131357?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 00:16","pubTimestamp":1783700165,"startTime":"0","endTime":"0","summary":"• 吉利德科学股价在一项实体瘤三期临床试验失败后下跌。\n• 强劲的就业数据推高了美债收益率，令今日生物科技板块估值承压。\n• 由于肿瘤产品组合销售时间表推迟，分析师可能会下调其盈利预测。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262023383-market-movers-gild-20260710","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","IE00B7SZLL34.SGD","LU2112291526.USD","LU1430594728.SGD","BK4568","BK4139","LU1571399168.USD","IE00B19Z3581.USD","LU1934455863.HKD","LU0861579265.USD","LU1037948541.HKD","LU1934455194.USD","IE00B19Z3B42.SGD","GILD","BMED","IE00BZ1G4Q59.USD","BK4585","LU0289739699.SGD","BK4578","LU0122379950.USD","BK4588","IBB","LU2468319806.SGD","LU1057294990.SGD","LU1061106388.HKD","IE00BSNM7G36.USD","LU0058720904.USD","IE00B3T34201.USD","IBBQ","LU0965509101.SGD","BIB","LU1674673691.USD","SG9999015986.USD","BBH","LU0965509283.SGD","LU1066051498.USD","LU0965509010.AUD","MEDI","LU2324357040.USD","BK4583","LU1066053197.SGD","LU1674673428.USD","LU0889565916.HKD","SG9999015952.SGD","LU0965508806.USD","BK4550","LU0882574055.USD","LU1934455277.USD","LU0823416689.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650118208","title":"BUZZ——美國股市動態-SK海力士、達美航空、Circle Internet","url":"https://stock-news.laohu8.com/highlight/detail?id=2650118208","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650118208?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 19:37","pubTimestamp":1783683425,"startTime":"0","endTime":"0","summary":".N** 费米公司FRMI.O：热点 - 因发行3.75亿美元可转换债券股价暴跌nL6N43C0K8** 吉利德科学公司GILD.O:** 礼来公司LLY.N:** 艾伯维公司ABBV.N:** 百健公司BIIB.O:热点 - 汇丰银行称生物制药并购交易有望创下年度新高nL4N43C0P3** 达美航空公司DAL.N:热点 - 因预测第三季度利润将超出预期，股价上涨nL4N43C0QQ** Circle Internet Group IncCRCL.N:热点 - 获最终监管批准在美国设立信托银行后股价上涨nL4N43C0SJ** SK海力士公司SKHY.O:热点 - 筹集265亿美元后，即将迎来备受期待的美国上市nL4N43C0TG","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4S43C0TU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0198837287.USD","LU2133065610.SGD","LU0889565916.HKD","LU0323591593.USD","LU0316494557.USD","RXL","IE000MB6IJN5.SGD","LU1035775433.USD","LU1934455863.HKD","BK4023","LU1232071149.USD","LU2237443622.USD","LU0882574139.USD","LU1861558580.USD","LU0133085943.USD","LU1066051498.USD","SGXZ51526630.SGD","IBB","IE00BLSP4452.SGD","LU2089284900.SGD","IE00BDGV0183.EUR","LU2361044949.HKD","IE00B2B36J28.USD","OZEM","LU1069344957.HKD","LU1814569148.SGD","LU0912757837.SGD","LU0683600562.USD","LU1778281490.HKD","IBLC","LLII","JETS","LU2756315318.SGD","BK4500","LU0823434740.USD","LU0985320562.USD","LU2237443465.HKD","BK4008","LU2462157665.USD","LU0861579265.USD","LU0114720955.EUR","CCUP","IE00BBT3K403.USD","LU2491050154.USD","LLYZ","LU2028103732.USD","WDNA","LU1267930490.SGD","LU2112291526.USD","IE00BGHQF631.EUR","LU0061475181.USD","LU1244550577.SGD","LU0106831901.USD","LU2129689431.USD","IE00B775H168.HKD","LU1983299246.USD","LU2129689514.USD","BK4585","LU2237443382.USD","LU0868494708.USD","SG9999001176.USD","LU2129689605.HKD","LU0203345920.USD","LU0124676726.USD","LU0210536198.USD","LU0949170772.SGD","CRCO","IE00BK4W5M84.HKD","LU0203202063.USD","LU1571399168.USD","IE00B3T34201.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU2168564495.EUR","LU0310800965.SGD","LU0158827781.USD","LU1629891620.HKD","SGXZ99366536.SGD","LU0234570918.USD","LU1720051108.HKD","IE00BN29S564.USD","LU0965509101.SGD","IE0002270589.USD","LU0672654240.SGD","LU0511384066.AUD","LU2896262040.SGD","LU0882574055.USD","LU0708994859.HKD","IE00B1XK9C88.USD","DAL","PBE","IE00BWXC8680.SGD","LU2237438978.USD","LU1861559042.SGD","LU1934455194.USD","LU2602419157.SGD","LU2087625088.SGD","LU1023059063.AUD","LU0432979614.USD","LU2265009873.SGD","LU1061106388.HKD","LU0661504455.SGD","IE0002141913.USD","IE00B7KXQ091.USD","IE00B19Z9Z06.USD","LU0965509010.AUD","LU2237443549.SGD","HRTS","ICRC","LU0266013472.USD","LU0289739343.SGD","LU2491049909.HKD","LU1037948897.HKD","LU2552382058.USD","BK4578","LU1988902786.USD","IXJ","LU0820561909.HKD","IE00B19Z9P08.USD","IE00B7SZLL34.SGD","BK4559","IE0001KFT4U8.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","SG9999014880.SGD","LU0097036916.USD","LU0689626769.HKD","LU1057294990.SGD","CRCA","LU0109391861.USD","FRMI","LU2168564065.EUR","SKHYV","LU2168563687.JPY","LU1066053197.SGD","LU1868836914.USD","LU2111349929.HKD","LU0795875169.SGD","LU1585245621.USD","LU0708995401.HKD","LU0225283273.USD","BIIB","IE00B19Z3B42.SGD","LU0353189763.USD","LU0820561818.USD","LU1718418525.SGD","LU2264538146.SGD","LU1929549753.HKD","LU2552382215.SGD","LU1323610961.USD","LU2023250330.USD","MEDX","IE0004445015.USD","XLV","LU2106854487.HKD","IHE","LU2237443895.HKD","LU1670627923.USD","LU0238689110.USD","IE00B894F039.SGD","IE00BKDWB100.SGD","LU1244550221.USD","IE00BVYPNV92.GBP","LU0094547139.USD","LU2746668461.USD","LU1093756168.USD","LU1732799900.SGD","LU1989772923.USD","GILD","LU0289961442.SGD","CRCG","LU0553294199.USD","SG9999015978.USD","LU0234572021.USD","LU0345770308.USD","SG9999015945.SGD","SGXZ81514606.USD","LU1791807156.HKD","ELIL","GB00BDT5M118.USD","LU2087621335.USD","LU1989772840.SGD","LU1623119135.USD","LU1074936037.SGD","LU2468319806.SGD","LU0058720904.USD","IE000SO60NU8.SGD","LU0738911758.USD","PPH","IE00BK4W5L77.USD","LU1861220207.SGD","CRCD","IE0000B7K699.USD","IE00BVYPNW00.USD","LU1804176565.USD","LU0052756011.USD","BK4583","LU2168564222.USD","LU0689472784.USD","LU0823416689.USD","CURE","LU0256863902.USD","LU1162221912.USD","LU0203201768.USD","LU2108987350.USD","LU0640476718.USD","IE00BZ1G4Q59.USD","LU2360107671.USD","IE00BFTCPJ56.SGD","LU1267930227.SGD","LU0096364046.USD","LU2361044865.SGD","IE00BKPKM429.USD","BK4007","LU0170899867.USD","LU2089984988.USD","SG9999015952.SGD","BK4566","CANC","LU2471134523.USD","SG9999014906.USD","LU0868494617.USD","BKCH","LU0057025933.USD","ELIS","LU1917777945.USD","LU0310800379.SGD","LU2324357040.USD","LU1291159041.SGD","LU0545039389.USD","LU1839511570.USD","LU2357305700.SGD","SG9999003800.SGD","LU1003077747.HKD","LU2089283258.USD","LU0942090050.USD","LU1496350502.SGD","LU0965509283.SGD","LU1934455277.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","ILDR","LLY","SG9999017495.SGD","LU2271345857.HKD","LU2360106947.USD","LU2417539215.USD","LU1267930573.SGD","LU2746668974.SGD","LU0823434583.USD","ABBV","SG9999018857.SGD","LU0128525929.USD","LU1861217088.USD","IE00BFMHRM44.USD","THNR","LU0466842654.USD","LU0320765059.SGD","LU0211327993.USD","LU0158827948.USD","LU1868836757.USD","LU0471298777.SGD","LU1989771016.USD","LU1093756325.SGD","MEDI","LU1127390331.HKD","LU2756315664.SGD","IE0004445239.USD","LU1720051017.SGD","SGXZ31699556.SGD","LU2213496289.HKD","LU1670628061.USD","IBBQ","LU2471134796.USD","LU2168564149.EUR","IE00BFSS7M15.SGD","BK4581","SG9999011175.SGD","LU0211328371.USD","BK4599","LU0320765992.SGD","BK4139","LU0069063385.USD","LU0310799852.SGD","AGNG","LU1868836591.USD","IE00B1BXHZ80.USD","FHLC","LU1366192091.USD","IE00BJJMRX11.SGD","IE0009355771.USD","LU2237443978.SGD","BK4550","BK4533","SG9999013999.USD","SG9999001440.SGD","LU2236285917.USD","LU2491050071.SGD","LU1037948541.HKD","LU0029864427.USD","LU0079474960.USD","LU0456855351.SGD","LU1674673691.USD","IE00BN8TJ469.HKD","VHT","LU0354030438.USD","SG9999015986.USD","LU1548497426.USD","BK4532","IE00B4JS1V06.HKD","LU2023250504.SGD","LU1064131342.USD","LU1267930730.SGD","LU1712237335.SGD","LU0256863811.USD","SG9999014898.SGD","LU2211815571.USD","IE00BJT1NW94.SGD","IE00B3PB1722.GBP","BIB","LU2750360997.AUD","LU1496350171.SGD","LU2471134879.HKD","JDOC","LU2750360641.GBP","BK4222","LU1551013425.SGD","LU0859254822.USD","IE000BZT7R73.USD","BK4568","FTXH","LU0417517546.SGD","LU0128525689.USD","LU1674673428.USD","LU0106261372.USD","LU0203347892.USD","LU1145028129.USD","IE00BLSP4239.USD","LU0345770993.USD","LU1974910355.USD","LU1244550494.USD","IE000WAW04H5.SGD","LU1668664300.SGD","IYH","LU0006306889.USD","LU0472753341.HKD","SKHY","LU0471298694.HKD","LU2461242641.AUD","BMED","LU0122379950.USD","LU0354030511.USD","LU2023251221.USD","LU1430594728.SGD","PJP","LU0098860793.USD","LU0820562030.AUD","IE00B42XCP33.USD","LU2063271972.USD","BBH","LU1280957306.USD","LU2361045086.USD","LU2357627491.SGD","LU0787776722.HKD","LU0964807845.USD","LU0353189680.USD","LU0795875086.SGD","IE000F7OJYX1.SGD","GDOC","LU1868837136.USD","LU0385154629.USD","BK4588","LU0786609619.USD","LU2552382132.HKD","IE00BFSS8Q28.SGD","LU1732800096.USD","LU1868837300.USD","SG9999014914.USD","IE0005OL40V9.USD","LLYX","BK4516","BK4534","IE00BSNM7G36.USD","LU1551013342.USD","SG9999018865.SGD","CRCL","LU0965508806.USD","SG9999001176.SGD","LU2456880835.USD","LU2471134952.CNY","LU0320765646.SGD","LU0943347566.SGD","IE00BJLML261.HKD","IE00BJJMRY28.SGD","LU2347655156.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650718438","title":"滙豐表示，生物製藥領域的併購交易有望創下年度新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2650718438","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650718438?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 18:33","pubTimestamp":1783679616,"startTime":"0","endTime":"0","summary":"BUZZ-汇丰表示，生物制药领域的并购交易有望创下年度新高7月10日-** 汇丰表示，生物制药领域的并购活动“正朝着创纪录的一年迈进”** 该券商指出，随着核心药品面临专利压力，大型制药企业正通过并购 (link) 来强化产品管线，并缓解对未来增长的担忧** 报告指出，截至4月，吉利德科学公司（GILD.O）在三笔收购中支付了约110亿美元的预付款；截至5月，礼来公司（LLY.N）的收购支出超过1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4T43C0Q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","ABBV","BK5011","BMED","HRTS","WDNA","CANC","XLV","LU2646069778.SGD","LU1267930730.SGD","LLY","RXL","ELIS","IYH","LLII","LU0820561909.HKD","IBBQ","LU0786609619.USD","BBH","PJP","IBB","LU1267930573.SGD","FHLC","IHE","THNR","LLYZ","LU0795875086.SGD","PBE","LLYX","MEDI","LU1934455277.USD","JDOC","LU0683600562.USD","ELIL","PPH","GSK.UK","ILDR","LU1323610961.USD","MEDX","BIB","BIIB","FTXH","LU1804176565.USD","GILD","OZEM","VHT","GDOC","IXJ","AGNG","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650913850","title":"福泰製藥(VRTX)股票7月8日盤中下跌3.09%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2650913850","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650913850?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 02:15","pubTimestamp":1783534535,"startTime":"0","endTime":"0","summary":"• Vertex Pharmaceuticals已同意以100亿美元现金收购Crinetics Pharmaceuticals。\n• 此次收购溢价超过Crinetics股价的100%。\n• 在估值创历史新高期间，高管们根据预先安排的交易计划出售了公司股票。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262018348-market-movers-vrtx-20260708","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","BBH","IE00BFTCPJ56.SGD","LU0058720904.USD","IDNA","LU0889565916.HKD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU2362540622.SGD","SG9999001176.SGD","LU2362541513.USD","IE00BJJMRZ35.SGD","PBE","LU0234570918.USD","LU1674673428.USD","IE00BZ9MQY76.HKD","LU1430594728.SGD","IE0002141913.USD","SG9999013999.USD","IE00B4R5TH58.HKD","IBBQ","LU1035775433.USD","LU1778281490.HKD","IE00B894F039.SGD","LU1674673691.USD","LU2462157665.USD","IE00B19Z3581.USD","LU2417539215.USD","IE00B19Z9Z06.USD","IE0002270589.USD","LU1069344957.HKD","BK4532","IBB","IE00B19Z9P08.USD","IE00B2B36J28.USD","BIB","LU2324357040.USD","LU1093756168.USD","LU0289739699.SGD","LU2362541273.HKD","BK4585","SGXZ57979304.SGD","VRTX","LU2237438978.USD","BK4139","LU1093756325.SGD","LU0432979614.USD","SG9999001176.USD","LU0417517546.SGD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649299398","title":"大摩解讀福泰製藥百億收購Crinetics：補齊內分泌管線佈局 兩大核心藥物打開增長空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2649299398","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649299398?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 20:01","pubTimestamp":1783512080,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研报，对福泰制药以100亿美元收购Crinetics的交易进行解读。此次收购将为福泰制药新增第五大业务支柱——内分泌药物，补齐公司管线布局。根据公告，每股85美元的收购价格较Crinetics周一的收盘价溢价了102%。值得注意的是，摩根士丹利担任福泰制药的财务顾问，协助该公司达成收购Crinetics的协议。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464871.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BIB","IE00B894F039.SGD","LU1244550221.USD","LU1585245621.USD","IDNA","SG9999001176.USD","LU0053666078.USD","LU1363072403.SGD","LU2237438978.USD","LU0210528500.USD","LU0823416689.USD","LU2487616109.SGD","LU0267386448.USD","LU1791710400.SGD","LU0079474960.USD","LU0390134368.USD","LU1720051017.SGD","IE00B19Z9P08.USD","LU0058720904.USD","IBB","BK4533","IE00BZ9MQY76.HKD","LU2236285917.USD","LU0882574139.USD","LU1720051108.HKD","LU2111349929.HKD","LU2133065610.SGD","BK4139","IAI","LU1674673691.USD","BK4588","LU0432979614.USD","LU2089284900.SGD","KBWB","IE0002270589.USD","LU2362541273.HKD","LU1732799900.SGD","IE0002141913.USD","BBH","IBBQ","BK4581","IE0009355771.USD","VRTX","LU2362540622.SGD","LU0098860793.USD","LU0528227936.USD","LU2456880835.USD","PBE","LU0109394709.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969921","title":"RBC Capital上調福泰製藥目標價至570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969921","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649969921?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 16:24","pubTimestamp":1783499090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0234570918.USD","BBH","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4207","IE00B19Z3B42.SGD","LU2324357040.USD","BK4139","BK4533","IBBQ","LU0310800379.SGD","LU0417517546.SGD","LU2462157665.USD","IE00B2B36J28.USD","IE00B19Z9Z06.USD","LU2417539215.USD","SG9999001176.USD","SG9999013999.USD","LU1093756325.SGD","BIB","PBE","IDNA","LU1267930573.SGD","LU2456880835.USD","LU0058720904.USD","LU2237438978.USD","BK4585","LU0128525929.USD","LU1093756168.USD","IBB","VRTX","LU0320765992.SGD","UDN","LU0289739699.SGD","LU1778281490.HKD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","IE00B19Z9P08.USD","GSIB","BK4567","LU0029864427.USD","IE00B4R5TH58.HKD","BK4532","RY","LU2362540622.SGD","IE00B894F039.SGD","LU0708994859.HKD","LU1069344957.HKD","LU0823416689.USD","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649930146","title":"吉利德科學(GILD)股票7月7日收盤上漲5.35%：原因全解讀","url":"https://stock-news.laohu8.com/highlight/detail?id=2649930146","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649930146?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 04:15","pubTimestamp":1783455335,"startTime":"0","endTime":"0","summary":"• 吉利德（Gilead）股价在三期艾滋病毒（HIV）临床试验取得成功结果后上涨。\n• 欧洲监管机构批准将Trodelvy用于一线癌症单药治疗。\n• 汇丰银行（HSBC）将吉利德股票评级上调至买入，理由是其管线估值被低估。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262017041-market-movers-gild-20260707","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","IE00B3T34201.USD","LU1037948541.HKD","LU2324357040.USD","LU0823416689.USD","LU1585245621.USD","LU1934455194.USD","LU0889565916.HKD","BBH","IE0002270589.USD","LU0965509101.SGD","SG9999015978.USD","LU0965508806.USD","LU0122379950.USD","BIB","BK4583","BK4568","LU2089984988.USD","LU1430594728.SGD","SG9999015952.SGD","LU1066053197.SGD","SG9999015986.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BK4578","LU1778281490.HKD","IBBQ","LU1023059063.AUD","LU1934455277.USD","LU2468319806.SGD","BMED","SG9999015945.SGD","LU0109394709.USD","BK4550","IBB","BK4532","BK4566","LU2087621335.USD","LU2112291526.USD","GILD","LU0965509010.AUD","LU1057294990.SGD","BK4139","LU0234570918.USD","IE00B19Z3581.USD","LU0289739699.SGD","MEDI","LU0965509283.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":153,"code":"91000000","status":"200"}]}}